(Q42545586)

2 November 2017

title

Comparative effects of topical ocular anti-allergy drugs on human conjunctival mast cells (English)

1 reference

2 November 2017

1 reference

Yanni JM

1

1 reference

2 November 2017

Miller ST

2

1 reference

2 November 2017

Gamache DA

3

1 reference

2 November 2017

Spellman JM

4

1 reference

2 November 2017

Xu S

5

1 reference

2 November 2017

Sharif NA

6

1 reference

2 November 2017

publication date

1 December 1997

1 reference

Annals of Allergy, Asthma & Immunology

2 November 2017

published in

1 reference

2 November 2017

volume

79

1 reference

2 November 2017

issue

6

1 reference

2 November 2017

page(s)

541-545

1 reference

Epidemiologic and socioeconomic aspects of allergic diseases

2 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963063-3

7 January 2021

Effects of topically applied occular decongestant and antihistamine

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963063-3

7 January 2021

Conjunctivitis of allergic origin: immunologic mechanisms and current approaches to therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963063-3

7 January 2021

The effect of disodium cromoglycate on the release of histamine and degranulation of rat mast cells induced by compound 48-80

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963063-3

7 January 2021

Double-blind comparison of levocabastine eye drops with sodium cromoglycate and placebo in the treatment of seasonal allergic conjunctivitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963063-3

7 January 2021

Topical levocabastine protects better than sodium cromoglycate and placebo in conjunctival provocation tests

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963063-3

7 January 2021

Immunopharmacological studies on TBX, a new antiallergic drug (2). Inhibitory effects on histamine release from peritoneal mast cells and lung fragments of rats

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963063-3

7 January 2021

Allergy in long-term hemodialysis. II. Allergic and atopic patterns of a population of patients undergoing long-term hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963063-3

7 January 2021

Mast cell heterogeneity

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963063-3

7 January 2021

Human conjunctival mast cell responses in vitro to various secretagogues.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963063-3

7 January 2021

Efficacy of nedocromil sodium and cromolyn sodium in an experimental model of ocular allergy.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963063-3

7 January 2021

Immunopharmacological studies on TBX, a new antiallergic drug (1). Inhibitory effects on passive cutaneous anaphylaxis in rats and guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963063-3

7 January 2021

Effect of sodium cromoglycate and nedocromil sodium on anti-IgE-induced and anti-IgG4-induced basophil degranulation.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963063-3

7 January 2021

Comparison of human lung and intestinal mast cells

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963063-3

7 January 2021

Comparison of the modulatory effect of ketotifen, sodium cromoglycate, procaterol and salbutamol in human skin, lung and tonsil mast cells

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963063-3

7 January 2021

Inhibition profiles of sodium cromoglycate and nedocromil sodium on mediator release from mast cells of human skin, lung, tonsil, adenoid and intestine

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963063-3

7 January 2021

The enhanced efficacy of disodium cromoglycate (DSCG) in DSCG predosed rats

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963063-3

7 January 2021

The in vitro and in vivo ocular pharmacology of olopatadine (AL-4943A), an effective anti-allergic/antihistaminic agent

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963063-3

7 January 2021

Allergic Conjunctivitis: A Survey of New Antihistamines

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963063-3

7 January 2021

Disodium Cromoglycate (FPL 670) (‘Intal’*): a Specific Inhibitor of Reaginic Antibody–Antigen Mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963063-3

7 January 2021

The effect of nedocromil on weal reactions in human skin

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963063-3

7 January 2021

Olopatadine (AL-4943A): ligand binding and functional studies on a novel, long acting H1-selective histamine antagonist and anti-allergic agent for use in allergic conjunctivitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963063-3

7 January 2021

10.1016/S1081-1206(10)63063-3

Identifiers

DOI

1 reference

2 November 2017

1 reference